The development of pterostilbene as a potential dietary supplement demonstrates the value of collaborations between the School of Pharmacy, NCNPR and USDA, said Barbara G. Wells, dean of the UM pharmacy school.
"These types of projects allow us to share expertise and help solve problems related to the health and well-being of people everywhere," Wells said. "We actively seek partnerships with other academic institutions and state and federal agencies, and we are pleased that this particular partnership has yielded such encouraging results."
The licensing agreement with ChromaDex is a prime example of how academic research can promote economic development, said Walt Chambliss, UM director of technology management.
"ChromaDex is just the kind of company we want to work with," Dr. Walter Chambliss, Director Technology Management, University of Mississippi, said. "They know the value of our research, and that's the key ingredient in a partnership like this.
"UM and USDA researchers working at Ole Miss share a common desire to translate research into commercial products. We couldn't be happier about our agreement with ChromaDex. It's just further testament to the ability of our researchers to do work that attracts commercial interest."
References to publications and white papers on the potential benefits of pterostilbene c
|SOURCE ChromaDex Corp.|
Copyright©2010 PR Newswire.
All rights reserved